NYSE:CCEL
Cryo Cell International Inc.
Cryo Cell International Inc.'s revenue fell 1.3% in fiscal 2025 to $31.6M while operating margin fell to 1.5%. Free cash flow was $5.2M, 16.6% of revenue, and the diluted share count fell 1.8%.Summary generated from Cryo Cell International Inc.'s SEC filings. Latest annual report filed Feb 27, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$31.6M
Revenue growth−1.3%
Revenue, 5-yr CAGR+0.3%
Gross margin76.6%
Operating margin1.5%
Net margin−7.7%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow$5.2M
FCF margin16.6%
Share count change−1.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 29 | 30 | 31 | 32 | 32 |
| Operating income | 4 | 4 | −12 | 3 | 0 |
| Net income | 2 | 3 | −10 | 0 | −2 |
| Free cash flow | 6 | −4 | 2 | 4 | 5 |
Recent filings
- 10-QQuarterly report for the period ended Aug 31, 2026
Oct 9, 2026 - 8-KOther events
Sep 14, 2026 - 4Insider transaction report
Aug 7, 2026 - 10-QQuarterly report for the period ended May 31, 2026
Jul 15, 2026 - 4Insider transaction report
May 29, 2026 - 8-KNotice of delisting or listing-rule failure
May 8, 2026 - 10-QQuarterly report for the period ended Feb 28, 2026
Apr 14, 2026 - 8-KNotice of delisting or listing-rule failure
Mar 12, 2026